- Home
- ADTX vs NCPL Comparison
ADTX vs NCPL Comparison
Compare ADTX & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- NCPL
- Stock Information
- Founded
- ADTX 2017
- NCPL 1984
- Country
- ADTX United States
- NCPL United States
- Employees
- ADTX N/A
- NCPL N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- NCPL Investment Managers
- Sector
- ADTX Health Care
- NCPL Finance
- Exchange
- ADTX Nasdaq
- NCPL Nasdaq
- Market Cap
- ADTX 5.3M
- NCPL 4.3M
- IPO Year
- ADTX 2020
- NCPL N/A
- Fundamental
- Price
- ADTX $1.54
- NCPL $2.68
- Analyst Decision
- ADTX
- NCPL
- Analyst Count
- ADTX 0
- NCPL 0
- Target Price
- ADTX N/A
- NCPL N/A
- AVG Volume (30 Days)
- ADTX 109.4K
- NCPL 188.9K
- Earning Date
- ADTX 05-15-2025
- NCPL 07-28-2025
- Dividend Yield
- ADTX N/A
- NCPL N/A
- EPS Growth
- ADTX N/A
- NCPL N/A
- EPS
- ADTX N/A
- NCPL N/A
- Revenue
- ADTX $55,323.00
- NCPL $812,612.00
- Revenue This Year
- ADTX $15,768.94
- NCPL N/A
- Revenue Next Year
- ADTX N/A
- NCPL $101.16
- P/E Ratio
- ADTX N/A
- NCPL N/A
- Revenue Growth
- ADTX N/A
- NCPL N/A
- 52 Week Low
- ADTX $1.34
- NCPL $1.41
- 52 Week High
- ADTX $27,200.00
- NCPL $11.90
- Technical
- Relative Strength Index (RSI)
- ADTX 35.55
- NCPL 68.54
- Support Level
- ADTX $1.42
- NCPL $2.13
- Resistance Level
- ADTX $1.63
- NCPL $2.85
- Average True Range (ATR)
- ADTX 0.13
- NCPL 0.26
- MACD
- ADTX 0.13
- NCPL 0.06
- Stochastic Oscillator
- ADTX 40.82
- NCPL 82.83
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.